DOI:
10.1055/s-00049561
South Asian Journal of Cancer
LinksClose Window
References
Jayakar V.
Using 2(nd) generation tyrosine kinase inhibitors in frontline management of chronic phase chronic myeloid leukemia.
South Asian J Cancer 2014;
3 (01) 87-91
We do not assume any responsibility for the contents of the web pages of other providers.